FULCRUM THERAPEUTICS INC (FULC)
US3596161097 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 25.56M | 35.10M | 35.40M | 57.10M | 96.70M | |||
| Marketable Securities | 210.66M | 167.80M | 182.80M | 55.90M | N/A | |||
| Receivables | 2.25M | 1.10M | 4.10M | 2.70M | 100.00K | |||
| Other Current Assets | 3.73M | 3.50M | 3.70M | 3.90M | 3.30M | |||
| Total Current Assets | 242.20M | 207.50M | 226.00M | 119.50M | 100.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.39M | 16.00M | 7.40M | 8.40M | 9.20M | |||
| Other Non-Current Assets | 3.10M | 3.20M | 1.60M | 1.70M | 1.20M | |||
| Total Non-Current Assets | 15.50M | 19.20M | 9.00M | 10.10M | 10.30M | |||
| TOTAL ASSETS | 257.69M | 226.70M | 235.00M | 129.60M | 110.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 0.00 | 100.00K | |||
| Accrued Expenses | 10.52M | 12.00M | 9.20M | 7.20M | 5.40M | |||
| Accounts Payable | 2.76M | 3.60M | 4.80M | 4.10M | 2.20M | |||
| Other Current Liabilities | 396.00K | 1.00M | 5.30M | 15.40M | 4.50M | |||
| Total Current Liabilities | 13.68M | 16.70M | 19.20M | 26.70M | 12.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 8.83M | 11.00M | 4.30M | 7.70M | 11.10M | |||
| Total Non-Current Liabilities | 8.83M | 11.00M | 4.30M | 7.70M | 11.20M | |||
| TOTAL LIABILITIES | 22.50M | 27.70M | 23.50M | 34.40M | 23.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -509.67M | -412.30M | -302.50M | -221.60M | -150.80M | |||
| Additional Paid In Capital | 744.94M | 612.00M | 514.40M | 316.80M | 237.90M | |||
| Common Shares | 62.00K | 100.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -136.00K | -800.00K | -400.00K | 0.00 | N/A | |||
| Shares Outstanding | 61.92M | 52.10M | 40.60M | 27.90M | 22.70M | |||
| Tangible Book Value per Share | 3.80 | 3.82 | 5.21 | 3.41 | 3.84 | |||
| Total Shareholders' Equity | 235.19M | 198.90M | 211.50M | 95.20M | 87.20M | |||
| TOTAL LIABILITIES AND EQUITY | 257.69M | 226.70M | 235.00M | 129.60M | 110.40M | |||
| Statistics | ||||||||
| Current Ratio | 17.71 | 12.43 | 11.77 | 4.48 | 8.27 | |||
| Return On Assets (ROA) | -37.77% | -48.46% | -34.40% | -54.65% | -81.35% | |||
| Return On Equity (ROE) | -41.39% | -55.24% | -38.23% | -74.39% | -102.99% | |||
All data in USD